✦ LIBER ✦

Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. a twenty-four—week controlled clinical trial

✍ Scribed by H. Hamdy; R. J. R. McKendry; E. Mierins; J. A. Liver

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 745 KB
Volume: 30
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780300401

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind study compari

A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-γ versus placebo in the treatment of rheumatoid arthritis

✍ Eric M. Veys; Charles-Joël Menkes; Paul Emery 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

Treatment of rheumatoid arthritis with a

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four–week, multicenter, randomized, double-blind, placebo-controlled trial

✍ Stanley Cohen; Eric Hurd; John Cush; Michael Schiff; Michael E. Weinblatt; Larry 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

Comparison of two schedules for administ

Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: A twenty-four–week, single-blind, randomized study

✍ Magdalena Luis; César Pacheco-Tena; Jorge Cazarín-Barrientos; Leticia Lino-Pérez 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Low-dose methotrexate with leucovorin (f

Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. results of a multicenter randomized, double-blind, placebo-controlled trial

✍ Jeffrey B. Shiroky; Carolyn Neville; John M. Esdaile; Denis Choquette; Michel Zu 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

Clinical and radiographic outcomes of fo

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

✍ Y. P. M. Goekoop-Ruiterman; J. K. De Vries-Bouwstra; C. F. Allaart; D. Van Zeben 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 3 views

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views